Cargando…
Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)
INTRODUCTION: There is an urgent need to identify patients with bladder cancer (BC) who are at high risk of recurrence or progression. Calgranulin A is a strong marker for muscle-invasive or advanced BC and recent studies have shown its potential for identifying patients at risk even in non-muscle-i...
Autores principales: | Nicklas, André P., Kramer, Mario W., Serth, Jürgen, Hennenlotter, Jörg, Hupe, Marie C., Reimer, Daniel U., Stenzl, Arnulf, Merseburger, Axel S., Kuczyk, Markus A., von Klot, Christoph-Alexander J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224005/ https://www.ncbi.nlm.nih.gov/pubmed/30232708 http://dx.doi.org/10.1007/s12325-018-0789-7 |
Ejemplares similares
-
Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinoma
por: Peters, Inga, et al.
Publicado: (2014) -
Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma
por: von Klot, Christoph-A, et al.
Publicado: (2014) -
Reduced mrna expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer
por: Tezval, Hossein, et al.
Publicado: (2013) -
Surgical approach in patients with T4 bladder cancer as primary treatment: Disaster or option with improved quality of life
por: Nagele, Udo, et al.
Publicado: (2008) -
Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer
por: Waalkes, Sandra, et al.
Publicado: (2010)